Pancreatic cancer
On this page:
The Ottawa Hospital is conducting cutting-edge research to improve our understanding of pancreatic cancer and develop better treatments. This page includes selected news stories about our pancreatic cancer research, links to researchers working in this area and related resources. Learn more below.
Research & News
Labs and Groups
These research teams may include multiple scientists, investigators, staff and trainees all working towards a common goal, or they can represent a single scientist and their team.
Addison Cancer Research Lab
Ardolino Cancer Immunology Lab
Auer Lab
Ilkow Lab
Clinical Trials
The following list of clinical trials at The Ottawa Hospital is pulled from ClinicalTrials.gov, which is hosted by the U.S. National Library of Medicine and only available in English. If you find a clinical trial that interests you, you can bring the information to the next appointment with your care team and ask if you are eligible for the study. If so, they may be able to refer you to the study team. If you email the study team directly, we can guarantee a response. Learn more about participating in research and clinical trials.
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors (NCT06586515)
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer View DetailsA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors (NCT06131840)
Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Pancreatic Ductal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Small Cell Lung Carcinoma View DetailsProspectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis (NCT02869802)
Cancer, Pancreatic Cancer View DetailsCessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours (NCT06345079)
Neuroendocrine Tumors View DetailsBOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours (NCT04421820)
Colorectal Cancer, Pancreatic Cancer, Gastric Cancers, Cholangiocarcinoma View DetailsA Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors (NCT04895709)
Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer, Non-Small-Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell, Urothelial Carcinoma, Pancreatic Adenocarcinoma, Melanoma, Ovarian Neoplasms, Triple Negative Breast Neoplasms View DetailsA Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) (NCT06428409)
Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancer View DetailsTesting the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer (NCT04340141)
Pancreatic Adenosquamous Carcinoma, Resectable Pancreatic Adenocarcinoma, Pancreatic Cancer View DetailsPublications
The following research publications from The Ottawa Hospital are pulled from PubMed, with publication date of 2020 or later. Note that PubMed is hosted by the U.S. National Library of Medicine and is only available in English.
Contrast-enhanced ultrasound as a non-invasive diagnostic modality for pancreatic ductal adenocarcinoma: The question of Ki67 for study validation.
2025-10-15 Go to publicationThe impact of dietary fiber consumption on human health: An umbrella review of evidence from 17,155,277 individuals.
2025-08-01 Go to publicationCanadian Association of Radiologists Cancer Diagnostic Imaging Referral Guideline.
2025-08-01 Go to publicationThe tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.
2025-04-04 Go to publicationAdministration of FOLFIRINOX for Advanced Pancreatic Cancer: Physician Practice Patterns During Early Use.
2025-02-25 Go to publication